share_log

KemPharm | PRER14A: Preliminary revised proxy soliciting materials

SEC announcement ·  Mar 13, 2023 16:29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more